Ask a doctor about a prescription for AXURA 10 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Axura 10 mg Film-Coated Tablets
Memantine Hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Pack
How Axura Works
Axura contains the active ingredient memantine hydrochloride.
Axura belongs to a group of medicines called anti-dementia medicines.
Memory loss in Alzheimer's disease is due to a disturbance in brain signals. The brain contains so-called N-methyl-D-aspartate (NMDA) receptors that are involved in the transmission of important nerve signals in learning and memory. Axura belongs to a group of medicines called NMDA receptor antagonists. Axura acts on these receptors, improving the transmission of nerve signals and memory.
What Axura is Used For
Axura is used in the treatment of patients with moderate to severe Alzheimer's disease.
Do Not Take Axura
Warnings and Precautions
In these situations, treatment should be carefully supervised and your doctor should regularly re-evaluate the clinical benefit of Axura.
If you have renal insufficiency (kidney problems), your doctor should closely monitor your kidney function and, if necessary, adjust the dose of memantine.
The use of memantine should be avoided in combination with other medicines such as amantadine (for the treatment of Parkinson's disease), ketamine (a medicine usually used to produce anesthesia), dextromethorphan (a medicine for the treatment of cough) and other NMDA antagonists.
Children and Adolescents
The use of Axura is not recommended in children and adolescents under 18 years of age.
Taking Axura with Other Medicines
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, the administration of Axura may produce changes in the effects of the following medicines, so your doctor may need to adjust the doses:
If you are hospitalized, inform your doctor that you are taking Axura.
Taking Axura with Food and Drinks
You should inform your doctor if you have recently changed or intend to change your diet substantially (e.g., from a normal diet to a strict vegetarian diet) or if you have renal tubular acidosis (RTA, excess of acid-producing substances in the blood due to kidney dysfunction) or severe urinary tract infections (urinary tract), as your doctor may need to adjust the dose of the medicine.
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
The use of memantine is not recommended in pregnant women.
Breastfeeding
Women taking Axura should stop breastfeeding.
Driving and Using Machines
Your doctor will inform you if your illness allows you to drive and use machines safely. Also, Axura may alter your reaction ability, so driving or operating machines may be inappropriate.
Axura Contains Sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; that is, it is essentially "sodium-free".
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, ask your doctor or pharmacist.
Posology
The recommended dose of Axura in adult and elderly patients is 20 mg administered once a day. To reduce the risk of side effects, this dose is gradually reached following the following daily scheme:
Week 1 | Half a 10 mg tablet |
Week 2 | One 10 mg tablet |
Week 3 | One and a half 10 mg tablets |
Week 4 and subsequent | Two 10 mg tablets once a day |
The normal starting dose is half a tablet once a day (1 x 5 mg) the first week. It is increased to one tablet a day (1 x 10 mg) the second week and to one and a half tablets once a day in the third week. From the fourth week onwards, the normal dose is two tablets administered once a day (1 x 20 mg).
Posology for Patients with Renal Insufficiency
If you have kidney problems, your doctor will decide the appropriate dose for your condition. In this case, your doctor should periodically monitor your kidney function.
Administration
Axura should be administered orally once a day. To get the most out of your medication, you should take it every day and at the same time. The tablets should be swallowed with a little water. The tablets can be taken with or without food.
Duration of Treatment
Continue taking Axura while it is beneficial for you. Your doctor should periodically evaluate the effects of your treatment.
If You Take More Axura Than You Should
If You Forget to Take Axura
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects are usually mild to moderate.
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 10,000 people):
Frequency Not Known (frequency cannot be estimated from the available data):
Alzheimer's disease has been associated with depression, suicidal ideation, and suicide. These events have been reported in patients treated with Axura.
Reporting of Side Effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system included in Annex V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month stated.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Axura
The active substance is memantine hydrochloride.
Each dosing device delivers 0.5 ml of solution containing 5 mg of memantine hydrochloride, equivalent to 4.16 mg of memantine.
The other ingredients are potassium sorbate, sorbitol E 420, and purified water.
Appearance and Packaging of the Product
Axura, oral solution, is a clear, colorless to slightly yellowish solution.
Axura, oral solution, is available in bottles of 50 ml, 100 ml, or a multiple pack with 500 ml (10 x 50 ml).
Not all pack sizes may be marketed.
Marketing Authorization Holder
Merz Pharmaceuticals GmbH
Eckenheimer Landstr. 100
D-60318 Frankfurt/Main
Germany
Manufacturer
Merz Pharma GmbH + Co. KGaA
Eckenheimer Landstr. 100
D-60318 Frankfurt/Main
Germany
You can obtain further information on this medicine by contacting the local representative of the marketing authorization holder.
Belgium/Belgique/Belgien Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | Lithuania Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Greece Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | Luxembourg/Luxemburg HANFF Global Health Solutions s.à r.l. Tel: +352 45 07 07-1 |
Czech Republic Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | Hungary Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Denmark Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | Malta Clinipharm Co. Ltd Tel: +356 21 43 74 15 |
Germany Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 - 0 | Netherlands Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Estonia Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | Norway Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Greece Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 - 0 | Austria Merz Pharma Austria GmbH Tel.: +43 1 865 88 95 |
Spain Merz Therapeutics Iberia, S.L.U. Tel. +34 91 117 89 17 | Poland Centrala Farmaceutyczna CEFARM SA Tel: +48 22 634 02 22 |
France Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | Portugal Merz Therapeutics Iberia, S.L.U. Tel. +34 91 117 89 17 |
Croatia Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | Romania Merz Pharmaceuticals GmbH Tel.: +49 (0)69 1503 – 0 |
Ireland Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | Slovenia Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 - 0 |
Iceland Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | Slovakia Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Italy Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 - 0 | Finland Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Cyprus Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 - 0 | Sweden Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Latvia Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 | United Kingdom (Northern Ireland) Merz Pharmaceuticals GmbH Tel: +49 (0)69 1503 – 0 |
Date of Last Revision of this Leaflet: (MM/YYYY).
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu.
Instructions for the Correct Use of the Dosing Device
The solution should not be poured or dispensed directly into the mouth from the bottle or dosing device. Measure the dose in a spoon or in a glass of water using the dosing device.
Remove the screw cap from the bottle:
The cap should be turned counterclockwise, completely unscrewed, and removed (fig. 1).
Assemble the dosing device on the bottle:
Remove the dosing device from the plastic bag (fig. 2) and place it on top of the bottle. Carefully insert the plastic tube into the bottle. Keep the dosing device on the neck of the bottle and turn it clockwise until it is firmly attached (fig. 3). The dosing device should only be screwed on once when starting use and should never be unscrewed.
How the dosing device works:
The dosing device head has two positions and can be easily turned
The dosing device head should not be pressed down while it is in the closed position. The solution can only be dispensed in the open position. To open, turn the dosing device head in the direction indicated by the arrow until it cannot be turned further (about one-eighth of a turn, fig. 4). The dosing device is then ready for use.
Prepare the dosing device.
When used for the first time, the dosing device does not dispense the correct amount of oral solution. Therefore, it must be prepared (primed) by pressing the dosing device head down completely five times in a row (fig. 5).
The solution thus dispensed should be discarded. The next time the dosing device head is pressed down completely (equivalent to one press), it already dispenses the correct dose (fig. 6)
Correct Use of the Dosing Device.
Place the bottle on a flat, horizontal surface, for example on a table, and it should only be used in a vertical position. Place a glass with a little water or a spoon under the spout. Press the dosing device head down firmly but calmly and steadily - not too slowly (fig. 7, fig. 8).
The dosing device head can then be released and is ready for the next press.
The dosing device should only be used with Axura solution in the provided bottle, not for other products or containers. If the dosing device does not work correctly, consult your doctor or pharmacist. Close the dosing device after using Axura.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for AXURA 10 mg FILM-COATED TABLETS – subject to medical assessment and local rules.